FRATARCANGELI Silvia;DEL RIO Alessandra;Ares Trading S.A;RINALDI Gianluca
发明人:
RINALDI Gianluca,FRATARCANGELI Silvia,DEL RIO Alessandra
申请号：
IL24911616
公开号：
IL249116D0
申请日:
2016.11.22
申请国别(地区):
IL
年份:
2017
代理人:
摘要：
The present invention relates to novel liquid pharmaceutical compositions of adalimumab, which include adalimumab or a biosimilar thereof, a citrate buffering agent/system such as sodium citrate/citric acid, and a sugar stabiliser such as trehalose. Such a combination of components furnishes formulations having a stability (e.g. on storage and when exposed to stress) which is comparable to or an improvement upon those known in the art, and with fewer ingredients. Such advances will help adalimumab treatments to become more widely available at lower cost, and prolong the viability of pre-loaded delivery devices (e.g. pre-filled syringes) to reduce unnecessary waste of the drug.
